These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7973463)

  • 1. Schizophrenic deficits: neuroleptics and the prefrontal cortex.
    Jobe TH; Harrow M; Martin EM; Whitfield HJ; Sands JR
    Schizophr Bull; 1994; 20(3):413-6; discussion 417-21. PubMed ID: 7973463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A theory of dopamine function and its role in cognitive deficits in schizophrenia.
    Cohen JD; Servan-Schreiber D
    Schizophr Bull; 1993; 19(1):85-104. PubMed ID: 8095737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients.
    Bédard MA; Scherer H; Delorimier J; Stip E; Lalonde P
    Can J Psychiatry; 1996 Sep; 41(7 Suppl 1):S21-4. PubMed ID: 8884048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Context, cortex, and dopamine: a connectionist approach to behavior and biology in schizophrenia.
    Cohen JD; Servan-Schreiber D
    Psychol Rev; 1992 Jan; 99(1):45-77. PubMed ID: 1546118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genetic and pharmacological effects on prefrontal cortical function in schizophrenia].
    Heinz A; Braus DF; Romero B; Gallinat J; Puls I; Juckel G; Weinberger DR
    Nervenarzt; 2004 Sep; 75(9):845-56. PubMed ID: 15372159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment.
    Snitz BE; MacDonald A; Cohen JD; Cho RY; Becker T; Carter CS
    Am J Psychiatry; 2005 Dec; 162(12):2322-9. PubMed ID: 16330597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: a computational reinforcement learning perspective.
    Frank MJ
    Schizophr Bull; 2008 Nov; 34(6):1008-11. PubMed ID: 18791075
    [No Abstract]   [Full Text] [Related]  

  • 9. Recent evidence for dopamine abnormalities in schizophrenia.
    Abi-Dargham A
    Eur Psychiatry; 2002 Aug; 17 Suppl 4():341s-347s. PubMed ID: 23573603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine and serotonin interactions in the prefrontal cortex: insights on antipsychotic drugs and their mechanism of action.
    Di Pietro NC; Seamans JK
    Pharmacopsychiatry; 2007 Dec; 40 Suppl 1():S27-33. PubMed ID: 18080940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine receptors and the dopamine hypothesis of schizophrenia.
    Seeman P
    Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The involvement of D-1 and D-2 dopamine receptors in the effects of neuroleptics and the pathogenesis of schizophrenia].
    Wielgosz M
    Psychiatr Pol; 1992; 26(5):357-64. PubMed ID: 1363827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
    Arnsten AF; Girgis RR; Gray DL; Mailman RB
    Biol Psychiatry; 2017 Jan; 81(1):67-77. PubMed ID: 26946382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine hypothesis of schizophrenia: making sense of it all.
    Toda M; Abi-Dargham A
    Curr Psychiatry Rep; 2007 Aug; 9(4):329-36. PubMed ID: 17880866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schizophrenia: D4 receptor elevation. What does it mean?
    Seeman MV
    J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia.
    Yang YK; Yeh TL; Chiu NT; Lee IH; Chen PS; Lee LC; Jeffries KJ
    Psychiatry Res; 2004 Sep; 131(3):209-16. PubMed ID: 15465290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
    Nørbak-Emig H; Ebdrup BH; Fagerlund B; Svarer C; Rasmussen H; Friberg L; Allerup PN; Rostrup E; Pinborg LH; Glenthøj BY
    Int J Neuropsychopharmacol; 2016 May; 19(5):. PubMed ID: 26819282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia.
    Keedy SK; Rosen C; Khine T; Rajarethinam R; Janicak PG; Sweeney JA
    Psychiatry Res; 2009 Apr; 172(1):16-23. PubMed ID: 19243925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.